Market Opportunity

Spinal Restoration is developing a new, minimally invasive therapy for the treatment of Discogenic Chronic Low Back Pain. Discogenic pain represents the single largest segment of the chronic low back pain market. The approximate 4 million patients annually that suffer from this condition have no widely accepted treatment options between conservative care and spinal fusion.

In recent years significant investments into new, motion preserving technologies have yielded several alternatives to spinal fusion. Significantly less progress has been made in minimally invasive technologies that can address discogenic pain patients who typically have less severe degeneration of the spine. Spinal Restoration and its clinician partners are focused on developing a minimally invasive, biologic treatment that specifically addresses the unique degenerative features of discogenic pain.

The market opportunity for a successful minimally invasive therapy for discogenic pain could conservatively exceed $2 billion annually.